National Telehealth Value Study

The National Telehealth Value Study, conducted by Strategic Healthcare Programs, LLC, (SHP) and sponsored by Honeywell HomMed, looked at how home telemonitoring return-on-investment could be calculated and used by home health providers. In the study, Honeywell HomMed provided various home agency sites across the  country with the telemonitoring equipment and clinical training necessary to  complete the study. The study was conducted between June 1, 2005 and November 30, 2005, and included a sample of 1,027 patients at 32 sites.

The results revealed hospital utilization rates that were less than expected for the monitored groups. Eleven of the 18 participating agencies experienced emergency care rates below the Centers for Medicare and Medicaid Services risk-adjusted scored for emergent care utilization for a similar patient mix. Of the 678 patients with a primary or secondary diagnosis of dyspnea, improvement averaged 63.5% in the non-monitored groups; total average improvement in the monitored group was 69.1%. Of the 819 patients that had the opportunity to improve in ambulation, on average 39.2% of the non-monitored patients experienced improvement. On average, 45.6% of the monitored groups experienced improvements.